Inhalation Friday, July 21, 2017
Skip Navigation LinksHome) Webinar 2017-09/12 Biopharmaceutical Consideration
Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.

Biopharmaceutical Considerations in Dry Powder Aerosol Drug Delivery

Tuesday, September 12, 2017

Time:  12:00 PM (Noon) – 1:30 PM ET

Presenter:  Anthony J. Hickey, PhD, DSc. Distinguished RTI Fellow, Research Triangle Institute and Emeritus Professor of Molecular Pharmaceutics, Eshelman School of Pharmacy and Adjunct Professor Biomedical Engineering, School of Medicine, The University of North Carolina at Chapel Hill.

Guest Moderator:  Daryl L. Roberts, PhD. Applied Particle Principles, LLC.

Webinar Cost: FREE

Webinar Details:  The benefits of dry powder inhaler drug products in disease management have been recognized with the increasing numbers of new technologies introduced over the last 20 years. Our knowledge and understanding of the critical attributes influencing the quality and performance of these unique drug products has evolved. The role of the physico-chemical properties has been a major focus of research endeavors and, while there are no predictive models, many of the key factors influencing powder behavior and aerosol delivery are understood.

The drug product performance interface between the patient and the device dictates lung deposition and clearance of an aerosol. Emphasis on in vitro/in vivo correlation (IVIVC) to predict the potential therapeutic outcome of drug therapy is based on product performance in response to patient effort, anatomy and physiology. The prospect of an inhaled Biopharmaceutical Classification System (BCS) has been explored. The foundation of a BCS will be key physical and biological parameters. Therefore, a crucial element of any IVIVC or BCS approach is an understanding of the interaction of the formulation with the inspiratory airflow and the implications for site of deposition and subsequent disposition. These interactions and their implications will be considered in terms of aerodynamic particle size distribution, delivered dose, rate of delivery, sites of deposition and clearance mechanisms.

Presenter Information:  Dr. Anthony J. Hickey is Distinguished RTI Fellow, at the Research Triangle Institute, Emeritus Professor of Molecular Pharmaceutics of the Eshelman School of Pharmacy, and Adjunct Professor Biomedical Engineering in the School of Medicine, at the University of North Carolina at Chapel Hill. He is the recipient of multiple awards and has published numerous papers and chapters in the pharmaceutical and biomedical literature. He has edited five texts on pharmaceutical inhalation aerosols and co-authored three others. He is founder of Cirrus Pharmaceuticals, Inc., acquired by Kemwell Pharma; founder of Oriel Therapeutics, Inc., acquired by Sandoz and founder of Astartein, Inc. Dr. Hickey has been a member of the Pharmaceutical Dosage Forms Expert Committee of the United States Pharmacopeia Chair of the sub-committee on Aerosols and formerly Chair of the Aerosols Expert Committee of the USP. He also conducts a multidisciplinary research program in the field of pulmonary drug and vaccine delivery for treatment and prevention of a variety of diseases.

Moderator Information:  XXXXXXXXXXXXXXX

Can’t attend?  If you register for a webinar but can't attend the live event, an archived version will be accessible online for 30 days once it concludes. This allows you to view the entire webinar presentation and Q&A session at a time most convenient to your schedule.

PDH Information:  If you are working on a certification or licensing program that allows Professional Development Hours, CSC Publishing Inc. will (upon request) provide a Certificate of Participation for our educational webinars put on by Inhalation. One certificate per registered participant will be sent if the webinar is viewed. You should check with your employer or local agency to confirm their specific PDH requirements. In many cases, our educational webinars will contribute toward these hours.

Visit our sponsors:

      Copyright 2017, CSC Publishing Inc. ALL Rights Reserved * Privacy policy